Skin marks is the S1 Fig title. حسب Mercedes Soto-González (20422078)

"…</p><p>Results</p><p>The IRD decreased after both exercise programs compared to baseline measurements in AB2 (mean difference: 3.06 mm, 95% CI: 1.06 to 5.05) and in AB5 (mean difference: 2.88 mm, 95% CI: 1.59 to 4.17), confirming the long-term effect of exercise. …"

Random forest plot showing the importance of predictors (top 10) for classifying LF progression based on the Mean Decrease in Gini index. حسب Emmanuel Kobla Atsu Amewu (13946765)

B2 decreases glycolytic intermediates in cells. حسب Craig Eyster (392633)

"…The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …"

Change in Mean Anxiety Scores Over time by group. حسب Shaaista Budhani (21030221)

Elevated concentrations of serum MMA among participants with decreased cognitive performance. حسب Yige Liu (11940344)

HSF2 reversed the decrease in the MMP induced by Atr. حسب Wen Wang (6570)

Decreased spindle microtubules in CAMSAP2 KO cells. حسب Naoko Nishizawa (20536299)

Boxplot comparing Ct values for HD in flies and clothes. حسب Philippe Ndzomo (17706039)

Tetrandrine decreases Mtb antigen presentation. حسب Elham Karamooz (2584474)

Mean KAP scores and standard deviation at different assessment times. حسب Chikondi Maluwa (20660522)

The stimulation with FA or GW501516 decreases DNA damage. حسب Shota Tanaka (339198)

HSF2 decreased the apoptosis rate of Caco-2 cells treated by Atr. حسب Wen Wang (6570)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

S1 Data. Bibliometric analysis. S2 Data. Estrogen level analysis. S3 Data. MicroCT quantification. S4 Data. Markers of bone metabolism. حسب Yan She (8639796)

K-means++ clustering algorithm. حسب Zhen Zhao (159931)

الموضوعات:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. حسب Francesca Catto (21253435)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات: